skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Status of gallium-67 in tumor detector

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5422595

The efficacy of gallium-67 citrate in detecting specific tumors is discussed. Tumors in which gallium-67 imaging is useful as a diagnostic tool include Hodgkin's disease, histiocystic lymphoma, Burkitt's lymphoma, hepatoma melanoma, and leukemia. It has not been found to be effective in diagnosing head and neck tumors, gastrointestinal tumors, genitourinary tract tumors, breast tumors, and pediatric tumors. Gallium may be useful in the evaluation of non-Hodgkin's lymphoma, testicular carcinoma, mesothelioma, and carcinoma of the lung. It may also be useful for determining response to treatment and prognosis in some neoplasms.

Research Organization:
Yale Univ. School of Medicine, New Haven, CT
DOE Contract Number:
EP-78-02-4625
OSTI ID:
5422595
Journal Information:
J. Nucl. Med.; (United States), Vol. 21:4
Country of Publication:
United States
Language:
English